Literature DB >> 24174210

Systemic overexpression of antizyme 1 in mouse reduces ornithine decarboxylase activity without major changes in tissue polyamine homeostasis.

Marko Pietilä1, Hiramani Dhungana, Anne Uimari, Reijo Sironen, Leena Alhonen.   

Abstract

Polyamines, spermidine, spermine and their precursor putrescine, are ubiquitous cell components essential for normal cell growth. Increased polyamine levels and enhanced biosynthesis have been associated with malignant transformation and tumor formation, and thus, the polyamines have been considered to be a meaningful target to cancer therapies. However, clinical cancer treatment trials using inhibitors of polyamine synthesis have been unsuccessful probably due to compensatory uptake of polyamines from extracellular sources. The antizyme proteins regulate both polyamine biosynthesis and transport, and thus, the antizymes could provide an efficient approach to control cellular proliferation compared to the mere inhibition of biosynthesis. To define the role of antizymes in proliferative processes associated with the whole animal, we have generated transgenic mice overexpressing mouse antizyme 1 gene under its own regulatory sequences. Antizyme 1 protein was abundantly expressed in various organs and the expressed antizyme protein was functional as ornithine decarboxylase activity was significantly reduced in all tissues analyzed. However, antizyme 1 overexpression caused only minor changes in tissue polyamine levels demonstrating the challenges in using the "antizyme approach" to deplete polyamines in a living animal. Neither were there any changes in cellular proliferation in the proliferative tissues of transgenic animals. Interestingly though, there was occurrence of abnormally high level of apoptosis in the non-proliferating part of the colon epithelia. Otherwise, the transgenic founder mice appeared healthy and out of seven founders six were fertile. However, none of the founders could transmit the transgene suggesting that the antizyme 1 overexpression may be deleterious to transgenic gametes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24174210     DOI: 10.1007/s11248-013-9763-y

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  31 in total

Review 1.  Mechanisms of protein degradation: an odyssey with ODC.

Authors:  Chaim Kahana; Gad Asher; Yosef Shaul
Journal:  Cell Cycle       Date:  2005-11-22       Impact factor: 4.534

2.  On the purification of L-ornithine decarboxylase from rat prostate and effects of thiol compounds on the enzyme.

Authors:  J Jänne; H G Williams-Ashman
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

3.  Identification and characterization of testis specific ornithine decarboxylase antizyme (OAZ-t) gene: expression in haploid germ cells and polyamine-induced frameshifting.

Authors:  Y Tosaka; H Tanaka; Y Yano; K Masai; M Nozaki; K Yomogida; S Otani; H Nojima; Y Nishimune
Journal:  Genes Cells       Date:  2000-04       Impact factor: 1.891

4.  Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis.

Authors:  D J Feith; L M Shantz; A E Pegg
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

5.  Limited blood-brain barrier transport of polyamines.

Authors:  W W Shin; W F Fong; S F Pang; P C Wong
Journal:  J Neurochem       Date:  1985-04       Impact factor: 5.372

6.  Stage- and cell-specific expression of the ornithine decarboxylase gene during rat and mouse spermatogenesis.

Authors:  A Kaipia; J Toppari; P Mali; M Kangasniemi; A A Alcivar; N B Hecht; M Parvinen
Journal:  Mol Cell Endocrinol       Date:  1990-10-01       Impact factor: 4.102

7.  Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene.

Authors:  Maria Elena Martinez; Thomas G O'Brien; Kimberly E Fultz; Naveen Babbar; Hagit Yerushalmi; Ning Qu; Yongjun Guo; David Boorman; Janine Einspahr; David S Alberts; Eugene W Gerner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

Review 8.  Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.

Authors:  O Heby; L Persson; M Rentala
Journal:  Amino Acids       Date:  2007-07-04       Impact factor: 3.520

9.  Targeting enzymes involved in spermidine metabolism of parasitic protozoa--a possible new strategy for anti-parasitic treatment.

Authors:  A Kaiser; A Gottwald; W Maier; H M Seitz
Journal:  Parasitol Res       Date:  2003-10-07       Impact factor: 2.289

10.  Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme.

Authors:  S Matsufuji; T Matsufuji; Y Miyazaki; Y Murakami; J F Atkins; R F Gesteland; S Hayashi
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

View more
  2 in total

1.  Role of ornithine decarboxylase/polyamine pathway in focal cerebral ischemia-reperfusion injury and its mechanism in rats.

Authors:  Li Ding; Xiao-Hong Ba
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Involvement of Antizyme Characterized from the Small Abalone Haliotis diversicolor in Gonadal Development.

Authors:  Wei-Dong Li; Min Huang; Wen-Gang Lü; Xiao Chen; Ming-Hui Shen; Xiang-Min Li; Rong-Xia Wang; Cai-Huan Ke
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.